Isolator-based Grade A/ISO 5 architectures minimize operator interventions, enabling robust contamination control and compliance with EU GMP Annex 1, FDA guidance, PIC/S, and ISO 14644. Lyophilization ...
Amid disruption to the outsourced fill/finish market, PCI is investing $100 million to more than double the capacity to fill ...
In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a ...
The platform now supports vials (2R–100H), prefilled syringes, cartridges, and bags, with end-to-end processes including formulation, compounding, sterile filtration, filling, stoppering, optional ...
BioTechnique broadens capabilities with end‑to‑end fill‑finish, advanced lyophilization development, and integrated multi‑temperature 3PL support. YORK, PA ...